The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
- PMID: 7790818
- PMCID: PMC2192102
- DOI: 10.1084/jem.182.1.219
VSports在线直播 - The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
VSports app下载 - Abstract
IP-10 is a member of the chemokine family of cytokines and is induced in a variety of cells in response to interferon gamma and lipopolysaccharide. The self-aggregation common to many chemokines, including IP-10, has hindered the identification of a specific IP-10 receptor. Using an IP-10 alkaline phosphatase fusion protein that fortuitously blocks this self-aggregation, we have identified an IP-10 binding site on a variety of cells including endothelial, epithelial, and hematopoietic cells. This binding site has a Kd of 25 nM, is inhibited by recombinant murine or human IP-10, and is dependent on the presence of cell surface heparan sulfate proteoglycans (HSPG) VSports手机版. This conclusion is based on the findings that IP-10 binding to cells is: (a) inhibited by heparin and heparan sulfate; (b) sensitive to a 1 M NaCl wash; (c) eliminated by treatment with heparinase and trypsin; and (d) absent on mutant CHO cells that do not express cell surface HSPG. Platelet factor 4 (PF4), but not IL-8, monocyte chemoattractant protein-1, RANTES, monocyte inflammatory protein (MIP)-1 alpha, or MIP-1 beta, can compete effectively with IP-10 for binding to the cell surface. Furthermore, IP-10 shares with PF4 the ability to inhibit endothelial cell proliferation (IC50 = 150 nM). These studies demonstrate specificity in the interaction of chemokines and HSPG, and they define IP-10 and PF4 as a distinct subset of chemokines sharing an HSPG-binding site and angiostatic properties. .
"V体育安卓版" References
-
- Proc Natl Acad Sci U S A. 1980 Jul;77(7):4216-20 - PubMed
-
- Thromb Res. 1980 Jul 1-15;19(1-2):129-37 - PubMed
-
- J Immunol. 1984 Mar;132(3):1479-86 - PubMed
-
- J Exp Med. 1984 Jul 1;160(1):55-74 - PubMed
-
- Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2267-71 - PubMed (VSports在线直播)
Publication types
- V体育官网入口 - Actions
MeSH terms (V体育平台登录)
- "V体育ios版" Actions
- "V体育ios版" Actions
- VSports注册入口 - Actions
- V体育ios版 - Actions
- V体育平台登录 - Actions
- VSports在线直播 - Actions
- Actions (V体育2025版)
- VSports在线直播 - Actions
- "VSports最新版本" Actions
- "VSports在线直播" Actions
- VSports手机版 - Actions
- "V体育ios版" Actions
- "VSports注册入口" Actions
- VSports注册入口 - Actions
- "VSports在线直播" Actions
Substances (V体育ios版)
- V体育2025版 - Actions
- V体育官网 - Actions
- "VSports在线直播" Actions
- "V体育2025版" Actions
- "VSports" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
